AP

Ajeet Pratap Singh

Active Director Additional Director DIN 11529284
DIN 11529284 First appointment Feb 2026 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value •••• Premium profile

About Ajeet Pratap Singh

Data last updated:

Ajeet Pratap Singh is an Additional Director at Svap Pharmaceuticals Private Limited (since 2026). The company operates in Trading. Svap Pharmaceuticals Private Limited reported revenue of ₹78.4 Lakh (FY 2025).

DIN 11529284
Primary Designation Additional Director
Industry Trading
First Appointment 07 Feb 2026
Largest company Svap Pharmaceuticals Private Limited · ₹78.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Svap Pharmaceuticals Private Limited U85191UP2013PTC055623
Additional Director07 Feb 2026₹78.4 Lakh (FY 2025)Active

Board colleagues of Ajeet Pratap Singh

Directorship timeline

Open interactive timeline →
Svap Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ajeet Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajeet Pratap Singh

Ajeet Pratap Singh currently holds 1 directorship: Svap Pharmaceuticals Private Limited (Additional Director, since 07 Feb 2026, revenue ₹78.4 Lakh (FY 2025)).

Ajeet Pratap Singh was first appointed on 07 Feb 2026 as Additional Director at Svap Pharmaceuticals Private Limited.

The current boards of Ajeet Pratap Singh's companies include Alok Kumar Mishra (Svap Pharmaceuticals Private Limited), Mala (Svap Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available